Skip to main content
Premium Trial:

Request an Annual Quote

Warnex to Sell Analytical Services Division

NEW YORK (GenomeWeb News) – Warnex today said that it has inked an agreement with an unnamed private company to purchase Warnex's Analytical Services division for more than C$1.1 million (US$1.1 million).

The deal comes around a week after Warnex sold its medical laboratories division to Gamma-Dynacare Medical Laboratories for C$7.5 million (US$7.3 million).

The Analytical Services division provides pharmaceutical and biotech firms with quality control services including chromatography, microbiology, and method development and validation. Laval, Quebec-based Warnex expects to close the deal around Jan. 15, 2012.

Warnex will receive C$400,000 in cash and an additional cash payment equal to the working capital of the division on the closing date, which is expected to be roughly C$700,000. In addition, Warnex will receive a 15 percent passive equity interest in the acquirer, and "other valuable consideration," it said.

"This transaction is consistent with our strategic plan and the commitment we made to reduce long-term debt," Michael Singer, chairman of the executive committee of the board of directors, said in a statement. "It also allows us to retain substantial upside in the Analytical Services business that we pioneered."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.